Ranbaxy Laboratories and Daiichi-Sankyo Company have started a synergistic initiative to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania as part of their global social contribution activities. 'Ranbaxy Community Health Care Society', a non-profit organization of Ranbaxy, will implement the initiative in India. The initiative in Cameroon and Tanzania will be implemented through an international NGO, Plan Japan, utilizing the Ranbaxy's accumulated and rich know-how and experience in providing mobile healthcare services.

The mobile clinics project will provide healthcare services in regions with limited healthcare access through the use of specialized vehicles for next five years with total investment of 200 million Japanese Yen. It will focus on basic healthcare, immunizations, maternal & child health services, health education, etc.

India is among the countries with the highest number of infant and maternal mortalities in the world, and Cameroon and Tanzania have some of the highest infant mortality rates and maternal mortality ratios among developing countries in Africa. All three countries also confront the lack of easy access to healthcare services. This initiative will contribute directly in improving the lives and health of citizens who lack such access in the three countries. It is also in alignment with the United Nation's global 'Millennium Development Goals' of reducing child mortality, improving maternal health, and combating HIV/AIDS, malaria and other diseases.